Global Proteomics Market - Forecasts from 2018 to 2023
Global proteomics market is expected to grow at a CAGR of 12.92% over the forecast period of 2017-2023. Proteomics is the study of the protein components in an organism. Proteomics involve large scale study of proteins, their role, functions, properties and structure. In other words, proteomics is the entire dataset of the proteins produced by the living organism. However, proteome is not constant and differs from cell to cell and changes over time. Proteomics provide significant biological information for various problems such as proteins interacting with a particular protein of interest, proteins localised to the subcellular compartment and proteins involved in the various biological processes.
Advancements in technologies driving the market for proteomics
Various advancements in the technologies have led to the growth of the proteomics market during the given time-frame. These developments have included advances in mass spectrometry (MS) technology, protein fractionation techniques, bioinformatics, etc. Dual mass analyzers such as LC/MS, GC/MS, FT-MS, and MALDI-TOF/TOF help to provide more detailed information about protein structure. Advances in the technology have led thousands of proteins to be resolved in a single gel. Apart from technological advancements, rising investments in R&D and rising demand for personalised medicine will further boost the market for the proteomics. However, lack of the skilled workforce coupled with high instrument and training costs may restrain the market during the forecast period.
North America to hold major share in proteomics markets
Geographically, North America is estimated to hold the major share in the market owing to the rapid adoption of the advanced technologies. Moreover, sophisticated healthcare infrastructure coupled with the rising interest in the personalised medicines will also boost the market in the region during the given projected period. Asia Pacific is expected to be the fastest growing region. The growth is attributed rising government funding for proteomics research in the region.
Market intelligence is presented in the form of analysis, charts, and graphics to help the clients in gaining faster and efficient understanding of the global proteomics market.
Major industry players profiled as part of the report are Proteomics International, Biognosys AG and Creative Proteomics (Division of Creative Dynamics Inc) among others.
Segmentation
Advancements in technologies driving the market for proteomics
Various advancements in the technologies have led to the growth of the proteomics market during the given time-frame. These developments have included advances in mass spectrometry (MS) technology, protein fractionation techniques, bioinformatics, etc. Dual mass analyzers such as LC/MS, GC/MS, FT-MS, and MALDI-TOF/TOF help to provide more detailed information about protein structure. Advances in the technology have led thousands of proteins to be resolved in a single gel. Apart from technological advancements, rising investments in R&D and rising demand for personalised medicine will further boost the market for the proteomics. However, lack of the skilled workforce coupled with high instrument and training costs may restrain the market during the forecast period.
North America to hold major share in proteomics markets
Geographically, North America is estimated to hold the major share in the market owing to the rapid adoption of the advanced technologies. Moreover, sophisticated healthcare infrastructure coupled with the rising interest in the personalised medicines will also boost the market in the region during the given projected period. Asia Pacific is expected to be the fastest growing region. The growth is attributed rising government funding for proteomics research in the region.
Market intelligence is presented in the form of analysis, charts, and graphics to help the clients in gaining faster and efficient understanding of the global proteomics market.
Major industry players profiled as part of the report are Proteomics International, Biognosys AG and Creative Proteomics (Division of Creative Dynamics Inc) among others.
Segmentation
- By Technology
- Microarrays
- Spectroscopy
- X-Ray Crystallography
- Chromatography
- Others
- By Reagents
- Microarrays Reagents
- Spectroscopy Reagents
- X-Ray Crystallography Reagents
- Chromatography Reagents
- Other Reagents
- By Application
- Discovery of Protein Biomarkers
- Study of Tumor Metastasis
- Neurotrauma and Neurology
- Renal Disease Diagnosis
- Fetal and Maternal Medicine
- Others
- By Geography
- North America
- United States
- Canada
- Others
- South America
- Brazil
- Argentina
- Others
- Europe
- United Kingdom
- Germany
- France
- Others
- Middle East and Africa
- Israel
- UAE
- Saudi Arabia
- Others
- Asia Pacific
- China
- India
- Australia
- South Korea
- Others
1. INTRODUCTION
1.1. Market Definition
1.2. Scope of the Study
1.3. Currency
1.4. Assumptions
1.5. Base, and Forecast Years Timeline
2. RESEARCH METHODOLOGY
2.1. Research Design
2.2. Secondary Sources
2.3. Validation
3. KEY FINDINGS OF THE STUDY
4. MARKET DYNAMICS
4.1. Drivers
4.2. Restraints
4.3. Opportunities and Market Trends
4.4. Market Segmentation
4.5. Porter’s Five Forces Analysis
4.5.1. Bargaining Power of Suppliers
4.5.2. Bargaining Power of Buyers
4.5.3. Threat of New Entrants
4.5.4. Threat of Substitutes
4.5.5. Competitive Rivalry in the Industry
4.6. Industry Value Chain Analysis
4.7. Industry Regulations
4.8. Scenario Analysis
5. GLOBAL PROTEOMICS MARKET FORECAST BY TECHNOLOGY
5.1. Microarrays
5.2. Spectroscopy
5.3. X-Ray Crystallography
5.4. Chromatography
5.5. Others
6. GLOBAL PROTEOMICS MARKET FORECAST BY REAGENTS
6.1. Microarrays Reagents
6.2. Spectroscopy Reagents
6.3. X-Ray Crystallography Reagents
6.4. Chromatography Reagents
6.5. Other Reagents
7. GLOBAL PROTEOMICS MARKET FORECAST BY APPLICATION
7.1. Discovery of Protein Biomarkers
7.2. Study of Tumor Metastasis
7.3. Neurotrauma and Neurology
7.4. Renal Disease Diagnosis
7.5. Fetal and Maternal Medicine
7.6. Others
8. GLOBAL PROTEOMICS MARKET FORECAST BY GEOGRAPHY
8.1. North America
8.1.1. The U.S
8.1.2. Canada
8.1.3. Mexico
8.1.4. Others
8.2. South America
8.2.1. Brazil
8.2.2. Argentina
8.2.3. Others
8.3. Europe
8.3.1. U.K.
8.3.2. France
8.3.3. Germany
8.3.4. Italy
8.3.5. Others
8.4. Middle East and Africa
8.4.1. Israel
8.4.2. UAE
8.4.3. Saudi Arabia
8.4.4. Others
8.5. Asia Pacific
8.5.1. China
8.5.2. India
8.5.3. Australia
8.5.4. South Korea
8.5.5. Others
9. COMPETITIVE INTELLIGENCE
9.1. Market Share Analysis
9.2. Strategies of Key Players
9.3. Recent Investments and Deals
10. COMPANY PROFILES
10.1. Biognosys AG
10.1.1. Overview
10.1.2. Financials
10.1.3. Product and Services
10.1.4. Recent Development
10.2. Creative Proteomics (Division of Creative Dynamics Inc)
10.2.1. Overview
10.2.2. Financials
10.2.3. Product and Services
10.2.4. Recent Development
10.3. Proteomics International
10.3.1. Overview
10.3.2. Financials
10.3.3. Product and Services
10.3.4. Recent Development
10.4. MRM Proteomics
10.4.1. Overview
10.4.2. Financials
10.4.3. Product and Services
10.4.4. Recent Development
10.5. Evotec AG
10.5.1. Overview
10.5.2. Financials
10.5.3. Product and Services
10.5.4. Recent Development
10.6. Proteome Factory
10.6.1. Overview
10.6.2. Financials
10.6.3. Product and Services
10.6.4. Recent Development
10.7. DC Biosciences
10.7.1. Overview
10.7.2. Financials
10.7.3. Product and Services
10.7.4. Recent Development
10.8. AYOXXA Biosystems GmbH
10.8.1. Overview
10.8.2. Financials
10.8.3. Product and Services
10.8.4. Recent Development
10.9. VProteomics
10.9.1. Overview
10.9.2. Financials
10.9.3. Product and Services
10.9.4. Recent Development
10.10. Dr Proteome, Inc.
10.10.1. Overview
10.10.2. Financials
10.10.3. Product and Services
10.10.4. Recent Development
List of Tables
List of Figures
1.1. Market Definition
1.2. Scope of the Study
1.3. Currency
1.4. Assumptions
1.5. Base, and Forecast Years Timeline
2. RESEARCH METHODOLOGY
2.1. Research Design
2.2. Secondary Sources
2.3. Validation
3. KEY FINDINGS OF THE STUDY
4. MARKET DYNAMICS
4.1. Drivers
4.2. Restraints
4.3. Opportunities and Market Trends
4.4. Market Segmentation
4.5. Porter’s Five Forces Analysis
4.5.1. Bargaining Power of Suppliers
4.5.2. Bargaining Power of Buyers
4.5.3. Threat of New Entrants
4.5.4. Threat of Substitutes
4.5.5. Competitive Rivalry in the Industry
4.6. Industry Value Chain Analysis
4.7. Industry Regulations
4.8. Scenario Analysis
5. GLOBAL PROTEOMICS MARKET FORECAST BY TECHNOLOGY
5.1. Microarrays
5.2. Spectroscopy
5.3. X-Ray Crystallography
5.4. Chromatography
5.5. Others
6. GLOBAL PROTEOMICS MARKET FORECAST BY REAGENTS
6.1. Microarrays Reagents
6.2. Spectroscopy Reagents
6.3. X-Ray Crystallography Reagents
6.4. Chromatography Reagents
6.5. Other Reagents
7. GLOBAL PROTEOMICS MARKET FORECAST BY APPLICATION
7.1. Discovery of Protein Biomarkers
7.2. Study of Tumor Metastasis
7.3. Neurotrauma and Neurology
7.4. Renal Disease Diagnosis
7.5. Fetal and Maternal Medicine
7.6. Others
8. GLOBAL PROTEOMICS MARKET FORECAST BY GEOGRAPHY
8.1. North America
8.1.1. The U.S
8.1.2. Canada
8.1.3. Mexico
8.1.4. Others
8.2. South America
8.2.1. Brazil
8.2.2. Argentina
8.2.3. Others
8.3. Europe
8.3.1. U.K.
8.3.2. France
8.3.3. Germany
8.3.4. Italy
8.3.5. Others
8.4. Middle East and Africa
8.4.1. Israel
8.4.2. UAE
8.4.3. Saudi Arabia
8.4.4. Others
8.5. Asia Pacific
8.5.1. China
8.5.2. India
8.5.3. Australia
8.5.4. South Korea
8.5.5. Others
9. COMPETITIVE INTELLIGENCE
9.1. Market Share Analysis
9.2. Strategies of Key Players
9.3. Recent Investments and Deals
10. COMPANY PROFILES
10.1. Biognosys AG
10.1.1. Overview
10.1.2. Financials
10.1.3. Product and Services
10.1.4. Recent Development
10.2. Creative Proteomics (Division of Creative Dynamics Inc)
10.2.1. Overview
10.2.2. Financials
10.2.3. Product and Services
10.2.4. Recent Development
10.3. Proteomics International
10.3.1. Overview
10.3.2. Financials
10.3.3. Product and Services
10.3.4. Recent Development
10.4. MRM Proteomics
10.4.1. Overview
10.4.2. Financials
10.4.3. Product and Services
10.4.4. Recent Development
10.5. Evotec AG
10.5.1. Overview
10.5.2. Financials
10.5.3. Product and Services
10.5.4. Recent Development
10.6. Proteome Factory
10.6.1. Overview
10.6.2. Financials
10.6.3. Product and Services
10.6.4. Recent Development
10.7. DC Biosciences
10.7.1. Overview
10.7.2. Financials
10.7.3. Product and Services
10.7.4. Recent Development
10.8. AYOXXA Biosystems GmbH
10.8.1. Overview
10.8.2. Financials
10.8.3. Product and Services
10.8.4. Recent Development
10.9. VProteomics
10.9.1. Overview
10.9.2. Financials
10.9.3. Product and Services
10.9.4. Recent Development
10.10. Dr Proteome, Inc.
10.10.1. Overview
10.10.2. Financials
10.10.3. Product and Services
10.10.4. Recent Development
List of Tables
List of Figures
